Thorne

SynaQuell

C-
N+ Score68
Longevity & NAD+Serving: 7.7 Gram(s)Type: Other Combinations

Thorne SynaQuell + supports healthy aging and cellular function with a powerful blend of NAD+ precursors, antioxidants, and essential amino acids. This advanced formula aids in energy production and overall longevity, helping you feel your best. Fuel your body's vitality and cellular health with SynaQuell +.

About This Product

SynaQuell by Thorne is a longevity & nad+ supplement containing 16 active ingredients. It has earned an N+ Score of 68/100 (Grade C-).

Notable clinical-dose ingredients include Docosahexaenoic Acid, Riboflavin, Magnesium.

N+ Score Breakdown

Ingredient Adequacy63/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +3 ingredient(s) at clinical dose levels
  • +Rich formula with 16 active ingredients

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (16 ingredients)

IngredientAmountDose Adequacy
Calories54.000 Calorie(s)N/A
Total Fat1.000 Gram(s)N/A
Docosahexaenoic Acid375.000 mgAdequate
Riboflavin100.000 mgOptimal
Magnesium220.000 mgOptimal
Total Carbohydrates5.000 Gram(s)N/A
L-Leucine1.250 Gram(s)Under
L-Isoleucine625.000 mgN/A
L-Valine625.000 mgN/A
trans-Resveratrol125.000 mgN/A
Betaine Anhydrous85.000 mgN/A
Nicotinamide Riboside Hydrogen Malate415.000 mgN/A
Beta-Hydroxybutyrate750.000 mgN/A
Glutathione, Reduced500.000 mgN/A
Meriva250.000 mgN/A
Ubiqsome50.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.